Sample preparation and high-pressure liquid-chromatography separation methods useful for the study of retinoic acid metabolism are reported. The sample preparation procedure does not cause significant degradation of retinoic acid, and the gradient high-pressure liquid-chromatography separation method gives excellent separation of the major metabolites of retinoic acid. These methods were used to examine the metabolites of retinoic acid in blood, trachea and lung, testes, kidneys and small intestine of vitamin A-deficient rats dosed subcutaneously with 2,ug of [11, 12-3H]retinoic acid. At 6 h after dosing, a total of eight metabolites of retinoic acid produced in vivo were found in the tissues examined. Of these, four were found in most of the epithelial tissues examined, and therefore may be of interest as possible active metabolites in the epithelial functions of vitamin A.
differentiation (Moore, 1957) . Retinoic acid satisfies the growth and epithelial differentiation functions, but not the visual or reproductive functions of vitamin A (Dowling & Wald, 1960; Thompson et aL, 1964) . Retinoic acid is a major metabolite of retinol in vivo (Emerick et al., 1967; KleinerBossaler & DeLuca, 1971; Ito et al., 1974a) and in a vitamin A-responsive system in vitro (Frolik et al., 1981a) when retinol is given at physiological doses. Retinol and retinoic acid are metabolized to similar products (Roberts & DeLuca, 1967; Ito et al., 1974b; Frolik et al., 198 la), and retinoic acid has a slight sparing effect on liver retinol stores (Krishnamurthy et al., 1963; Nelson et al., 1964; Keilson et al., 1979) . That retinoic acid is metabolically related to retinol as described and substitutes for retinol in some of its essential functions suggests that retinoic acid is a normal intermediate of vitamin A metabolism closer to the form of the vitamin responsible for maintenance of growth and of epithelial differentiation.
Although much work on the metabolism of retinoic acid has been done, few studies have examined the metabolism of physiological amounts of retinoic acid. Many studies have been done with pharmacological doses of retinoic acid, and others Abbreviation used: h.p.l.c., high-pressure liquid chromatography.
* No reprints are available from the authors.
Vol. 206
have been directed to the metabolism of retinoic acid in non-target tissues (Zachman et al., 1966a,b; Dunagin et al., 1966; Lippel & Olson, 1968; Rietz et al., 1974; Hanni et al., 1976; Hanni & Bigler, 1977; Frolik et al., 1980 Frolik et al., , 1981b Zile et al., 1980) . The relevance of these studies to the physiological metabolism of retinoic acid in its target tissues is not known. Notable exceptions to the above are the studies by McCormick et al. (1978, 1980) , Frolik et al. (1978 Frolik et al. ( , 1979 and Ito et al. (1974b) . McCormick et al. (1978 McCormick et al. ( , 1980 identified 5,6-epoxyretinoic acid and showed it to be a physiological metabolite of retinoic acid found in epithelial tissues of vitamin A-deficient rats. Frolik et al. (1979) identified all-trans-4-hydroxyretinoic acid and all-trans-4-oxoretinoic acid, and showed that these compounds were produced from low concentrations of retinoic acid in their vitamin A-responsive tracheal organculture system. The physiological metabolism of retinoic acid in several tissues of the vitamin Adeficient rat was studied by Ito et al. (1974b) . Unfortunately, the chromatographic systems available at that time gave poor separation of the polar metabolites of retinoic acid. Most of the studies done thus far have centred on the isolation and identification of metabolites generated in vivo or in vitro rather than on the overall metabolism of retinoic acid. A study of the metabolites present in target tissues where retinoic acid exerts the same action may reveal a functionally important metabolite(s). In the present paper we report new sample preparation and chromato- (Nutley, NJ, U.S.A.) . This material was impure and was purified as described below. The non-radioactive retinoid standards all-trans-1-hydroxymethyl-4-oxoretinoic acid, all-trans-4-oxoretinoic acid, all-trans-4-hydroxyretinoic acid, all-trans-5,6-epoxyretinoic acid and 13-cis-retinoic acid were also generously provided by Hoffmann-La Roche. all-trans-Retinoic acid and all-trans-retinol were purchased from Eastman Organic Chemicals (Rochester, NY, U.S.A.), and methyl retinoate was prepared by the reaction of all-trans-retinoic acid with diazomethane (Zile et al., 1980) . All solvents used were either h.p.l.c. grade or glass-distilled and filtered through a 0.45,um filter (Millipore, Bedford, MA, U.S.A.). Antioxidants were added to the water and methanol used in tissue sample preparation. The water contained 150,ug of n-propylgallate/ml, and the methanol contained 50,ug each of n-propylgallate and butylated hydroxytoluene/ml.
Animals
Male weanling albino rats were purchased from Holtzman Co. (Madison, WI, U.S.A.) and fed on a purified vitamin A-deficient diet (DeLuca et al., 1963) . In 5-6 weeks most animals reached a weight-gain plateau, and 2-3 days later were used for experiments on retinoic acid metabolism.
Determination ofphysiological dose
Three dosages of all-trans-retinoic acid, 1. first on a Buchi Rotavapor-R apparatus (Brinkman Instruments) and then under a stream of N2 to a volume of 1 ml. This sample was applied to and eluted from a Waters Associates (Milford, MA, U.S.A.) Sep Pak C18 cartridge in methanol. An average of 80% of the methanol/water-phase radioactivity was recovered from this step. After concentration under a stream of N2, a portion of the sample containing 3 x 105-5 x lOs d.p.m. was used in the h.p.l.c. separation of the compounds present. The recovery of sample radioactivity from h.p.l.c. was always greater than 95%.
High-pressure liquid chromatography
The [11,1 2-3H]retinoic acid received from Hoffmann-La Roche was purified to be greater than 90% all-trans isomer and less than 4% cis isomers by using reverse-phase h.p.l.c. The A, all-trans-1-hydroxymethyl-4-oxoretinoic acid; B, all-trans-4-oxoretinoic acid; C, all-trans-4-hydroxyretinoic acid; D, all-trans-5,6-epoxyretinoic acid; E, 13-cis-retinoic acid; F, all-trans-retinoic acid; G, all-trans-retinol; H, methyl retinoate. The continuous line (-) shows the relative absorbance at 340nm and the broken line (----) 
Peak assignment and quantitative determination
Peaks were assigned only if they displayed reproducible peak shape and elution volume relative to the internal standards. A peak was designated as near detection limit if in no more than two of the tissue metabolite determinations the peak was poorly resolved over background. Peak 8 proved to be due to retinoic acid. The amount of metabolite in a tissue was calculated from the specific radioactivity of the [1 1, 12-3H]retinoic acid dose assuming an absence of unlabelled retinoids from the vitamin A-deficient rats and that no 3H was lost in conversion of retinoic acid into the metabolite.
Results

Determination ofphysiological dose
An experiment to determine the dosage of retinoic acid necessary to elicit a response in vivo was performed. The subcutaneous injection of 1.5, 3.0 and 6.0,ug of all-trans-retinoic acid per day into vitamin A-deficient rats gave weight-gain responses (means + S.D.) of +0.6 + 2.4 (n = 20), +2.6 + 2.5 (n = 15) and +5.1 + 1.7 g/day (n = 9) respectively. Thus 1.5,ug of retinoic acid per day, when given in two doses, one every 12 h, resulted in maintenance of rat weight. The higher dosages gave positive weightgain responses. On the basis of these results, 2,ug doses of purified [ 11, administered in the study of tissue metabolites. Sample-preparation control experiment
The production of metabolites from retinoic acid as artifacts during the sample preparation was tested. Representative h.p.l.c. profiles from procedure-check and negative-control samples are shown in Fig. 2. A comparison of these profiles shows that no major peaks appeared as artifacts as a result of sample manipulation. The procedure-check samples had a small radioactive peak (0.9% of total radioactivity) that co-migrated with the all-trans-5,6-epoxyretinoic acid internal standard and an increase in the amount of radioactivity that was eluted with the 13-cis-retinoic acid internal standard. Two small peaks, found only in the blood procedurecheck samples, migrated in the same region as tissue metabolite peaks 9 and 10 ( Fig. 3a) and accounted for 2.7 and 1.5% of the eluted radioactivity respectively. No radioactive peaks migrating in the regions of tissue metabolite peaks 1-7 were found.
Experiments on retinoic acid metabolism
The metabolites of all-trans-retinoic acid in four epithelial tissues and the blood of vitamin A-deficient rats were examined. Table 1 shows the recovery of dose in each of these tissues. The h.p.l.c. separation profiles of the radioactive compounds extracted from the tissues are shown in Fig. 3 . Ten metabolite peaks were reproducibly found. Tables 2 and 3 give the percentages of total radioactivity and the values for pmol/g of tissue respectively for the metabolites.
Of the known physiological metabolites of retinoic acid, only 13-cis-retinoic acid and all-trans-4-oxoretionic acid co-migrated with tissue-sample radioactivity. The radioactivity that was eluted with the 13-cis-retinoic acid internal standard was found in all tissues. A quantitatively important metabolite peak that co-migrated with the all-trans-4-oxoretinoic acid internal standard was found only in the small intestine, and represented approx. 2.7% of the tissue radioactivity or 2.Opmol/g of mucosa.
In other tissues this component was present in very small amounts. A comparison of the h.p.l.c. profiles shows that peaks 3, 7 and 8 are present in all of the tissues examined. Also, peaks 4 and 6 are reproducibly present in all of the tissues examined except kidney, where they are present only at the limit of detection.
Discussion
If the metabolism of retinoic acid that is pertinent to its physiological actions in or to its elimination from target tissues is to be examined, three conditions must be met. Metabolites must be examined (1) in retinoic acid target tissues, (2) in an animal given a physiological dose of retinoic acid, and (3) at a time when retinoic acid is exerting its biological effect in the tissues examined. The state of differentiation of many epithelial tissues is affected by the vitamin A status of the animal (Moore, 1957; Rojanopo et al., 1980) . Administration of retinyl palmitate, retinol or retinoic acid to the vitamin A-deficient rat reverses most of the epithelial lesions brought about by deficiency Vol. 206 (Moore, 1957; Dowling & Wald, 1960; Thompson et al., 1964; Rojanopo et al., 1980) , implicating epithelial tissues as a class of vitamin A-and retinoic acid-responsive tissues. For this reason, we have examined the metabolism of retinoic acid in epi- Tissue Blood (n = 9) Testes (n = 6) Trachea + lungs (n = 10) Small intestine (n = 6) Kidney (n = 10) Recovery (%) 0.83 + 0.25 0.32 +0.10 0.22 +0.10 4.3 + 1.5 2.5 + 1.3 thelial tissues of the rat. It is well known that retinoic acid can also substitute for retinol in the maintenance of growth (Dowling & Wald, 1960; Malathi et al., 1963; Zile & DeLuca, 1968) . In the growth assay reported in the present paper, the lowest dosage of all-trans-retinoic acid tested, 1.5,ug/day (0.75,g every 12h), gave weight maintenance in the retinol-depleted rat. The higher supplementation dosages, 3.0 and 6.0,g/day (1.5 and 3.0,g every 12h), gave positive weight-gain responses. As in the growth assay, the metabolism of retinoic acid was examined in the vitamin A-deficient rat. A 2,ug dose was administered to each rat and the animals were Table 2 . Metabolites ofretinoic acid in tissues after the administration of [11, The values are the percentages of the total tissue radioactivity found in the retinoic acid metabolism experiments. For full experimental details see the text. All results are expressed as means ± S.D. Radioactivity recovered in tissues (% of total) Metabolite Blood peak no.
(n = 9) Vol. 206 killed 6 h later. This 6 h time point was chosen as the midpoint of the 12 h interval over which a growth effect was seen as a result of supplementation with low doses (0.75,ug) of retinoic acid. It was assumed that the maintenance of epithelial differentation and overall rat growth were of comparable sensitivity to retinoic acid supplementation, and therefore that the metabolism of retinoic acid pertinent to its action in epithelial tissues would be seen.
A total of nine unidentified metabolite peaks in the h.p.l.c. profiles from epithelial tissues and blood of retinoic acid-dosed vitamin A-deficient rats were found. Additionally, we have found radioactive peaks co-migrating with all-trans-4-oxoretinoic acid in the small-intestine preparations and peaks co-migrating with 13-cis-and all-trans-retinoic acid in all tissue preparations. However, control experiment results show that all-trans-retinoic acid can be converted into artifact peaks that are eluted with peaks 9 and 10. These components account for the percentage of the sample radioactivity that is eluted as peaks 9 and 10 in the experimental blood samples. The control experiments also show that the alltrans-retinoic acid, to some degree, is converted into 13-cis-retinoic acid during preparation of tissue samples. Therefore the 13-cis-retinoic acid found in the experimental samples cannot be solely attributed to isomerization in vivo. Thus we have found that a total of eight unidentified metabolite peaks and one previously identified compound, 4-oxoretinoic acid, are made in the retinoic acid-dosed vitamin Adeficient rat. A tissue-to-tissue comparison of these metabolites found may point out which of these metabolites belong to a pathway of retinoic acid metabolism common to retinoic acid-responsive epithelial tissues. Metabolite peaks 3, 4, 6 and 7 are found in most of the epithelial tissues examined, and therefore may be of interest for future isolation and identification work.
At We have also failed to find all-trans-4-hydroxyretinoic acid and all-trans-4-oxoretinoic acid as quantitatively important metabolites of retinoic acid in trachea + lung samples. Frolik et al. (1979) showed that these compounds were made in their tracheal organ-culture system from a low (5 nM) concentration of retinoic acid. The difference in results may be due to differences in the retinoic acid-metabolizing systems of the rat and of the hamster, and in the conditions employed. In the work by Frolik et al. (1978) , retinoic acid metabolism was examined in hamster tracheal organ culture 24 h after the addition of retinoic acid, whereas in the work reported in the present paper the metabolites from the trachea and lung of the vitamin A-deficient rat were examined 6 h after administration of a physiological dose of retinoic acid. The most thorough work exploring the distribution and disposition of retinoic acid in tissues of the vitamin A-deficient rat has been done by Ito et al. (1974b) . Their work included studies of the time-course distribution of the dose radioactivity and a study of the tissue distribution of the metabolite peaks found 6h after dosing. A comparison of the values presented in the present paper and those found by Ito et aL (1974b) for the recovery of dose and the ratio of polar metabolites of retinoic acid to retinoic acid found in the tissues were not in close agreement. Our experiment differed from that performed by Ito et al. (1974b) in the route and amount of retinoic acid administered. In the study by Ito et aL (1974b), vitamin A-deficient rats received 10-13,ug of retinoic acid by intrajugular injection, whereas we injected 2,ug doses by the subcutaneous route. These procedural differences may explain the differences found in the comparison of the 6 h time-point data reported by Ito et al. (1974b) and the results given in the present paper.
Eight unidentified metabolites of retinoic acid, which account for a large proportion of total tissue radioactivity, have been found in epithelial tissues of the vitamin A-deficient rat. Although four of these metabolite peaks may be part of a common metabolic pathway for retinoic acid, whether they are activation or excretory metabolites of retinoic acid is not known.
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